CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.

@article{Arias2008CPAPDP,
  title={CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.},
  author={Miguel A Arias and Francisco Garc{\'i}a-R{\'i}o and Alberto Alonso-Fern{\'a}ndez and Angel Hernanz and Roc{\'i}o Hidalgo and Virgilio Mart{\'i}nez-Mateo and Sonia Bartolom{\'e} and Lu{\'i}s Rodr{\'i}guez-Padial},
  journal={The European respiratory journal},
  year={2008},
  volume={32 4},
  pages={1009-15}
}
There is increasing evidence that inflammation plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnoea (OSA). No previous works have studied levels of soluble tumour necrosis factor-alpha receptor (sTNFR)-1 in patients with OSA. The aims of the present study were to examine serum levels of sTNFR-1 and the effect of nasal continuous positive airway pressure (CPAP) in patients with OSA. A prospective, randomised, placebo-controlled… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients

  • T Ueland, J Kjekshus, SS Froland
  • J Am Coll Cardiol
  • 2005

Similar Papers

Loading similar papers…